Search
01/12/2022
Urolithiasis in anomalous kidneys: RIRS or PCNL, this is the question. May ECIRS be the answer?
Esperto, F, Juliebo-Jones, P, Keller, EX, Tailly, T, Mykoniatis, I, DE Coninck, V, Pietropaolo, A, Talso, M, Sener, ET, Tonyali, S, Hameed, BMZ, Ventimiglia, E, Tzelves, L, Tsaturyan, A, Emiliani, E, Papalia, R, Scarpa, RM. Urolithiasis in anomalous kidneys: RIRS or PCNL, this is the question. May ECIRS be the answer?. Minerva Urology And Nephrology. 2022; 74(6)DOI:10.23736/S2724-6051.22.05208-9. PMID:36629810. IF:4.900(Q1/2D).
30/11/2022
beta-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease
Mohaupt, P, Pons, ML, Vialaret, J, Delaby, C, Hirtz, C, Lehmann, S. beta-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01125-1. PMID:36451155. IF:9.000(Q1/1D).
29/11/2022
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
Zhang, YT, Ghose, U, Buckley, NJ, Engelborghs, S, Sleegers, K, Frisoni, GB, Wallin, A, Lleo, A, Popp, J, Martinez-Lage, P, Legido-Quigley, C, Barkhof, F, Zetterberg, H, Visser, PJ, Bertram, L, Lovestone, S, Nevado-Holgado, AJ, Shi, L. Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.1040001. PMID:36523958. IF:4.800(Q2/3D).
28/11/2022
Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data
Plana, MN, Arevalo-Rodriguez, I, Fernandez-Garcia, S, Soto, J, Fabregate, M, Perez, T, Roque, M, Zamora, J. Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data. BMC Medical Research Methodology. 2022; 22(1)DOI:10.1186/s12874-022-01788-2. PMID:36443653. IF:4.000(Q2/3D).